Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs33980500
rs33980500
TRAF3IP2 ; TRAF3IP2-AS1
T 0.820 GeneticVariation GWASCAT Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture. 26626624

2015
dbSNP: rs33980500
rs33980500
TRAF3IP2 ; TRAF3IP2-AS1
0.820 GeneticVariation BEFREE However, the dominant PsA-associated TRAF3IP2 (Act1) gene single-nucleotide polymorphism (rs33980500) results in decreased binding of Act1 to TRAF6. 23116200

2012
dbSNP: rs33980500
rs33980500
TRAF3IP2 ; TRAF3IP2-AS1
T 0.820 GeneticVariation GWASDB Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. 20953186

2010
dbSNP: rs33980500
rs33980500
TRAF3IP2 ; TRAF3IP2-AS1
T 0.820 GeneticVariation GWASCAT Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. 20953186

2010
dbSNP: rs33980500
rs33980500
TRAF3IP2 ; TRAF3IP2-AS1
0.820 GeneticVariation BEFREE A stratified analysis of our datasets including only PsA cases (1,922 cases compared to 8,037 controls, P = 4.57 × 10⁻¹² for rs33980500) suggested that TRAF3IP2 represents a shared susceptibility for PsV and PsA. 20953188

2010
dbSNP: rs13017599
rs13017599
NONOP2
G 0.810 GeneticVariation GWASCAT Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture. 26626624

2015
dbSNP: rs13017599
rs13017599
NONOP2
0.810 GeneticVariation GWASDB However, conditional analysis indicated that rs13017599, rather than rs702873, accounts for the PsA association at REL. 22170493

2012
dbSNP: rs13017599
rs13017599
NONOP2
0.810 GeneticVariation GWASCAT However, conditional analysis indicated that rs13017599, rather than rs702873, accounts for the PsA association at REL. 22170493

2012
dbSNP: rs13017599
rs13017599
NONOP2
0.810 GeneticVariation BEFREE Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. 22328738

2012
dbSNP: rs702873
rs702873
LINC01185
0.810 GeneticVariation GWASCAT However, conditional analysis indicated that rs13017599, rather than rs702873, accounts for the PsA association at REL. 22170493

2012
dbSNP: rs702873
rs702873
LINC01185
0.810 GeneticVariation BEFREE However, conditional analysis indicated that rs13017599, rather than rs702873, accounts for the PsA association at REL. 22170493

2012
dbSNP: rs702873
rs702873
LINC01185
0.810 GeneticVariation GWASDB However, conditional analysis indicated that rs13017599, rather than rs702873, accounts for the PsA association at REL. 22170493

2012
dbSNP: rs12188300
rs12188300 		T 0.800 GeneticVariation GWASDB Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. 20953186

2010
dbSNP: rs12188300
rs12188300 		T 0.800 GeneticVariation GWASCAT Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. 20953186

2010
dbSNP: rs13191343
rs13191343
HLA-B ; HLA-C
T 0.800 GeneticVariation GWASCAT Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. 20953186

2010
dbSNP: rs13191343
rs13191343
HLA-B ; HLA-C
T 0.800 GeneticVariation GWASDB Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. 20953186

2010
dbSNP: rs13190932
rs13190932
TRAF3IP2 ; TRAF3IP2-AS1
0.710 GeneticVariation GWASCAT Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis. 30552173

2019
dbSNP: rs12044149
rs12044149
C1orf141
T 0.710 GeneticVariation GWASCAT Among identified psoriasis risk variants, three were more strongly associated with PsC than PsA (rs12189871 near HLA-C, p = 5.0 × 10(-19); rs4908742 near TNFRSF9, p = 0.00020; rs10888503 near LCE3A, p = 0.0014), and two were more strongly associated with PsA than PsC (rs12044149 near IL23R, p = 0.00018; rs9321623 near TNFAIP3, p = 0.00022). 26626624

2015
dbSNP: rs12044149
rs12044149
C1orf141
0.710 GeneticVariation BEFREE Among identified psoriasis risk variants, three were more strongly associated with PsC than PsA (rs12189871 near HLA-C, p = 5.0 × 10(-19); rs4908742 near TNFRSF9, p = 0.00020; rs10888503 near LCE3A, p = 0.0014), and two were more strongly associated with PsA than PsC (rs12044149 near IL23R, p = 0.00018; rs9321623 near TNFAIP3, p = 0.00022). 26626624

2015
dbSNP: rs13190932
rs13190932
TRAF3IP2 ; TRAF3IP2-AS1
0.710 GeneticVariation BEFREE We replicated PsA associations at HLA-C and IL12B and identified a new association at TRAF3IP2 (rs13190932, P = 8.56 × 10⁻¹⁷). 20953186

2010
dbSNP: rs10865331
rs10865331 		0.700 GeneticVariation GWASCAT Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis. 30552173

2019
dbSNP: rs114212579
rs114212579
CYP21A2 ; SKIV2L
0.700 GeneticVariation GWASCAT Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis. 30552173

2019
dbSNP: rs114265779
rs114265779
TRIM26
0.700 GeneticVariation GWASCAT Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis. 30552173

2019
dbSNP: rs114383947
rs114383947
MUC22
0.700 GeneticVariation GWASCAT Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis. 30552173

2019
dbSNP: rs114598684
rs114598684
MICA
0.700 GeneticVariation GWASCAT Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis. 30552173

2019